Skip to content
Screener

Opko Health OPK Diagnostics — Gross Profit

Other segment segments

Pharmaceutical
$63.93M+108%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOClinical Diagnostics — Gross Profit
$181.8M+2.4%
Flexible Solutions International logo
FSIGross Profit
$1.89M-3.7%
Orthofix Medical Inc. logo
OFIXGross Profit
$149.71M+7.3%
SharkNinja logo
SNGross Profit
$860.34M+21.5%
Taboola.com Ltd. logo
TBLAGross Profit
$139.48M+2.9%
Dynatrace logo
DTGross Profit
$451.1M+15.0%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
(In thousands) / Revenue from services: / PharmaceuticalFor the three months ended June 30, 2026 / —For the three months ended June 30, 2025 / —For the six months ended June 30, 2026 / —For the six months ended June 30, 2025 / —
$83,563$107,405$162,003$214,737
Gross margin:
Pharmaceutical$63,930$30,684$93,643$54,978
Diagnostics16,08718,71832,13137,044
Corporate
$80,017$49,402$125,774$92,022
Selling, general and administrative:
Pharmaceutical$13,916$13,197$28,121$25,907

Item 1. Financial Statements

FAQ

What is Opko Health's diagnostics — gross profit?
Opko Health (OPK) reported diagnostics — gross profit of $16.09M in Q2 2026.
How has Opko Health's diagnostics — gross profit changed year-over-year?
Opko Health's diagnostics — gross profit decreased by 14.1% year-over-year, from $18.72M to $16.09M.
What is the long-term trend for Opko Health's diagnostics — gross profit?
Over 3 years (2022 to 2025), Opko Health's diagnostics — gross profit has grown at a -21.1% compound annual growth rate (CAGR), from $128.08M to $62.92M.
What does diagnostics — gross profit mean?
Calculated as the revenue generated from diagnostic services minus the direct costs of providing those services. This metric measures the fundamental profitability of the diagnostics segment before accounting for operating expenses. It is a key indicator of pricing power and cost control within the laboratory and testing operations.

Ask your AI about Opko Health's diagnostics — gross profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude